Market Outlook

By 2035, the U.S. Joint Replacement Devices Market is expected to reach approximately USD 24.76 billion, expanding at a CAGR of 6.42% during the forecast period 2026–2035. The market was valued at USD 13.29 billion in 2025, with historical analysis covering 2021 to 2024. Values in this report are expressed in USD billions.

For market-sizing purposes, joint replacement devices include primary and revision implants used in knee, hip, shoulder, ankle, elbow, wrist, and complex joint reconstruction procedures. The scope also includes procedure-specific instruments, bone cement and fixation accessories, patient-specific components, and the proportion of robotic, navigation, planning, and digital-enablement revenue directly attributable to joint replacement procedures. Trauma fixation, spinal implants, sports medicine products, arthroscopy-only devices, rehabilitation equipment, and pharmaceuticals are excluded unless they are directly bundled with a joint replacement procedure.

The market value is estimated to have increased from USD 10.36 billion in 2021 to USD 11.03 billion in 2022, USD 11.73 billion in 2023, USD 12.49 billion in 2024, and USD 13.29 billion in 2025. Historical expansion was supported by the normalization of elective orthopedic procedures after pandemic-related disruption, recovery of hospital operating-room capacity, continued growth in outpatient arthroplasty, and accelerating adoption of robotic-assisted knee and hip replacement.

The market estimate has been triangulated against established U.S. and global joint replacement revenue benchmarks, procedure-volume trends, manufacturer category sales, implant pricing, revision demand, and the expanding economic contribution of enabling technology. Published market benchmarks have placed the U.S. joint replacement market on a path toward approximately USD 15.76 billion by 2030 under a narrower definition, while the global joint replacement devices market was estimated at USD 23.4 billion in 2024. The higher growth trajectory used in this report reflects its inclusion of allocated robotics, digital planning, patient-specific instruments, advanced materials, and outpatient workflow technologies in addition to implants.

The U.S. joint replacement devices industry is one of the most economically durable segments of the orthopedic medical device market. Demand is anchored by osteoarthritis, degenerative joint disease, inflammatory arthritis, avascular necrosis, traumatic joint damage, implant wear, periprosthetic joint infection, obesity-related joint loading, and the functional expectations of an aging but increasingly active population. Approximately 21.3% of U.S. adults reported diagnosed arthritis in 2024, while osteoarthritis accounted for approximately 9.9 million office-based physician visits in the latest available national ambulatory-care data.

The commercial opportunity extends beyond procedure growth. The revenue mix is shifting toward premium implants, cementless fixation, highly cross-linked polyethylene, advanced porous metals, robotic-assisted placement, patient-specific planning, smart instrumentation, and ambulatory surgery center solutions. Hospitals and surgeons are placing greater value on systems that can improve implant alignment, reduce inventory complexity, support reproducible procedures, document outcomes, and facilitate same-day discharge.

The market is also becoming more concentrated around complete procedural ecosystems. Manufacturers are increasingly expected to supply implants, reusable instruments, disposable accessories, robotic or navigation platforms, preoperative planning, service contracts, surgeon training, data analytics, and post-procedure outcomes support. As a result, competitive advantage is moving away from the performance of an isolated implant toward the clinical and economic value of the entire joint replacement workflow.

 

Introduction

According to the U.S. Joint Replacement Devices Market Report, the industry is shaped by the intersection of large disease burden, aging demographics, advanced orthopedic infrastructure, established reimbursement pathways, and strong patient demand for restored mobility. Joint replacement is no longer viewed only as a final intervention for elderly patients with severe arthritis. It is increasingly managed as a coordinated episode that begins with patient selection and prehabilitation, continues through implant planning and surgery, and extends into home recovery, patient-reported outcomes, and long-term implant surveillance.

The United States had approximately 61.2 million people aged 65 or older in 2024, representing an increase of 3.1% from the previous year. By 2030, all members of the baby-boom generation will be at least 65 years old. This demographic transition expands the number of patients entering the highest-utilization age groups for hip, knee, and shoulder arthroplasty while also increasing the number of patients living long enough to require revision procedures.

Demand is not limited to older patients. A growing number of adults in their forties, fifties, and early sixties are seeking treatment because they wish to remain employed, participate in recreational activity, and preserve independence. These patients often place greater value on implant longevity, range of motion, stability, rapid recovery, and confidence in returning to activity. Their expectations are contributing to demand for advanced bearing surfaces, bone-preserving procedures, partial knee replacement, anterior hip approaches, personalized alignment, and robotic-assisted surgery.

Obesity is another important demand variable. The prevalence of obesity among U.S. adults was approximately 40.3% during August 2021 through August 2023, and prevalence among adults aged 40–59 reached 46.4%. Obesity does not automatically determine the need for arthroplasty, but sustained mechanical loading can accelerate symptomatic degeneration in weight-bearing joints and complicate surgical planning, rehabilitation, infection prevention, and implant selection.

The American Joint Replacement Registry has become an increasingly important source of evidence for U.S. arthroplasty practice. Its 2025 annual report analyzed more than 4.4 million procedures collected from 2012 through 2024 across all 50 states, the District of Columbia, and Puerto Rico. The scale of the registry illustrates the maturity of hip and knee replacement in the United States and the growing importance of implant surveillance, patient-reported outcomes, and evidence-based procurement.

The market is clinically concentrated in hip and knee replacement, but shoulder and ankle replacement are expanding faster from smaller revenue bases. Knee replacement remains the largest device category because of its high procedure volume, broad osteoarthritis population, large revision pool, and increasing adoption of robotic assistance. Hip replacement provides a stable combination of primary, fracture-related, conversion, and revision demand. Shoulder replacement is benefiting from growth in reverse shoulder arthroplasty, while total ankle replacement is gaining acceptance as implants and surgical techniques improve.

From 2026 to 2035, the most important strategic transition will be the movement from implant-centric selling to episode-centric orthopedic platforms. Health systems will increasingly evaluate technologies according to their effect on operating-room productivity, instrument processing, length of stay, post-acute utilization, complications, readmissions, patient-reported outcomes, and 90-day episode expenditure. Suppliers that can connect implant performance with workflow and economic evidence will be better positioned than companies competing primarily through surgeon preference and product price.

 

Key Market Drivers: What’s Fueling the U.S. Joint Replacement Devices Market Boom?

The first major market driver is the large and persistent burden of arthritis and degenerative joint disease. Arthritis affects tens of millions of U.S. adults, and prevalence rises sharply with age. In 2022, 53.9% of adults aged 75 and older reported diagnosed arthritis. Although many patients are managed through weight reduction, exercise, physical therapy, injections, assistive devices, and pain management, a substantial population eventually progresses to end-stage joint deterioration for which replacement becomes the most effective reconstructive option.

The second driver is growth in hip and knee arthroplasty volumes. Contemporary projections indicate that by 2040, annual U.S. primary total hip arthroplasty volume could exceed 719,000 procedures, while primary total knee arthroplasty could approach 1.22 million procedures. Revision demand is also expected to expand as the installed base of implants grows and patients receive primary replacements at younger ages.

This volume growth creates recurring demand for femoral stems, acetabular shells, liners, femoral heads, tibial trays, femoral components, patellar components, modular augments, cones, sleeves, stems, bone cement, revision extraction instruments, and infection-management solutions. Revision procedures typically require more components, longer operating time, greater inventory support, and higher-value reconstruction systems than uncomplicated primary procedures, making revision arthroplasty commercially important despite lower absolute procedure volume.

The third driver is the aging U.S. population. Joint replacement utilization rises substantially among adults aged 65 and older, and the expansion of this population supports long-term procedural visibility. Aging also contributes to a larger population with osteoporosis, fracture-related joint damage, rotator-cuff deficiency, and multiple chronic conditions that complicate treatment. Manufacturers are responding with implants designed for variable bone quality, enhanced fixation, greater constraint, and complex revision reconstruction.

The fourth driver is the migration of appropriate procedures to outpatient hospital departments and ambulatory surgery centers. Total knee and total hip replacement can now be performed on an inpatient or outpatient basis when patient selection, surgical capability, anesthesia, and recovery support are appropriate. Medicare payment policies and the expansion of ASC infrastructure are reinforcing this shift. CMS indicated that its 2025 outpatient and ASC policies affected approximately 3,500 hospitals and 6,100 ambulatory surgery centers.

Outpatient migration materially changes device purchasing behavior. ASCs require smaller instrument footprints, predictable case times, efficient sterilization, reduced tray counts, responsive logistics, and commercially sustainable implant pricing. A large hospital may tolerate extensive inventory and multiple vendor platforms, whereas an orthopedic ASC often prefers standardized systems that can support high throughput with limited storage and staffing.

The economic case is strengthening. A study of 47,261 total knee arthroplasty patients reported lower 90-day costs for ASC procedures than for hospital outpatient department procedures, with average costs of approximately USD 35,634 versus USD 38,096. The ASC cohort also experienced lower inpatient admission and emergency-department utilization rates, although patient selection and clinical suitability remain essential considerations.

The fifth driver is the expansion of robotic-assisted and digitally planned arthroplasty. Robotics has progressed from a premium differentiator in a small number of tertiary hospitals to a strategic platform used by community hospitals, physician-owned facilities, and orthopedic ASCs. Demand is supported by surgeon interest in reproducibility, patient-specific planning, component positioning, gap assessment, alignment strategy, and procedural documentation.

The commercial effect of robotics extends beyond capital-system revenue. Robotic platforms can influence implant pull-through, create long-term account retention, support data collection, and strengthen vendor relationships across multiple sites. Health systems therefore assess the total contractual package, including capital acquisition, service fees, disposables, implant commitments, training, software upgrades, and the ability to use the platform across knee, hip, shoulder, or other procedures.

The sixth driver is the rise of value-based joint replacement care. CMS has used bundled-payment approaches to encourage coordination across the procedure and recovery period. The forthcoming Comprehensive Care for Joint Replacement Expanded Model is scheduled to begin nationwide on October 1, 2027. It will hold participating hospitals accountable for quality and spending across a 90-day episode for eligible lower-extremity joint replacement patients. The earlier CJR model generated an estimated USD 112.7 million in net savings during performance years 2021–2023 while maintaining quality.

This policy direction favors devices and workflows that reduce complications, readmissions, post-acute facility use, and avoidable variation. Manufacturers will increasingly need to demonstrate how their systems affect the complete episode rather than focusing solely on implant survivorship.

The seventh driver is growth in revision and complex reconstruction. The expanding installed base of primary implants inevitably creates long-term demand for revision surgery. Infection, aseptic loosening, instability, polyethylene wear, periprosthetic fracture, implant malposition, and progressive bone loss can require complex reconstruction. Revision cases support demand for modular stems, metaphyseal cones, augments, constrained components, custom triflange implants, megaprostheses, antibiotic-loaded cement, and specialized extraction systems.

The eighth driver is hospital and physician investment in orthopedic service lines. Joint replacement programs can support commercially valuable elective procedure volume, specialist recruitment, ASC development, rehabilitation networks, and regional referral capture. Hospitals increasingly use destination joint centers, same-day surgery pathways, robotic technology, and patient navigation programs to differentiate themselves in competitive metropolitan markets.

The ninth driver is patient preference for mobility and independence. Patients increasingly research implant technologies, robotic surgery, outpatient eligibility, surgeon volume, recovery timelines, and facility quality before choosing care. Although final device selection remains a clinical decision, consumer awareness influences provider marketing and hospital investment. Systems able to support a clear, evidence-based patient value proposition can strengthen surgeon recruitment and procedural growth.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. joint replacement devices market is increasingly focused on personalization, reproducibility, implant longevity, workflow efficiency, and data-supported outcomes. The next generation of competition will not be defined solely by whether a manufacturer offers a successful knee or hip implant. It will depend on how effectively the company integrates planning, instrumentation, robotics, implants, analytics, and recovery support.

Robotic-assisted surgery is the most visible innovation category. The leading systems use combinations of preoperative imaging, image-free registration, intraoperative mapping, alignment planning, soft-tissue assessment, controlled bone preparation, and digital verification. The technology is moving in two directions. Large robotic-arm platforms are becoming multi-specialty systems, while compact handheld technologies are being developed for hospitals and ASCs that require smaller footprints and lower operational complexity.

The value proposition is also evolving. Early robotic marketing emphasized accuracy, but U.S. procurement committees now ask whether systems increase case capacity, reduce variability between surgeons, shorten the learning curve, decrease instrument requirements, support outpatient care, and create measurable improvements in patient outcomes. Vendors must therefore connect technical performance to health-system economics.

Personalized alignment is another major innovation area. Conventional mechanical alignment remains widely used, but many surgeons are evaluating kinematic, restricted kinematic, functional, and patient-specific alignment philosophies. Digital planning and robotic execution allow surgeons to consider native anatomy, ligament balance, bone morphology, and range-of-motion objectives when positioning components. This is particularly relevant in knee replacement, where patient dissatisfaction can persist despite technically acceptable implant placement.

Advanced materials are improving fixation and bearing performance. Highly cross-linked polyethylene remains central to hip and knee bearing systems. Porous titanium, tantalum-like structures, additive manufacturing, hydroxyapatite coatings, oxidized zirconium, advanced ceramics, and improved surface treatments are being used to support biological fixation, reduce wear, and manage bone loss. Material selection is increasingly matched to patient age, bone quality, activity level, allergy concerns, and revision risk.

Cementless knee replacement is receiving greater commercial attention. Cemented fixation remains a major standard of care, but improved porous surfaces and increasing surgeon familiarity are supporting cementless adoption in selected patients. The segment is strategically attractive because it can command premium pricing and align with younger, more active patients, although long-term evidence, patient selection, and surgeon technique remain critical.

Three-dimensional printing is changing complex reconstruction. Additive manufacturing supports porous implant structures, patient-specific augments, custom acetabular components, oncologic reconstruction, and solutions for severe bone loss. Customization is especially valuable when conventional component inventories cannot adequately address pelvic discontinuity, unusual anatomy, previous implant failure, or large skeletal defects.

Shoulder replacement innovation is being driven by reverse shoulder arthroplasty, improved glenoid fixation, augmented baseplates, convertible platforms, stemless designs, and three-dimensional planning. Reverse shoulder systems have expanded the treatable population by addressing conditions involving rotator-cuff deficiency and complex shoulder degeneration. Navigation and robotic assistance are beginning to enter shoulder arthroplasty, creating a potential new enabling-technology cycle.

Total ankle replacement is also advancing. Historically, ankle fusion was frequently used for end-stage ankle arthritis, but improved implant designs, instrumentation, imaging, and patient selection are increasing interest in motion-preserving ankle replacement. The category remains much smaller than hip or knee replacement, but its growth rate and strategic value are attracting investment from broader orthopedic companies.

Smart instrumentation and sensors represent another emerging layer. Disposable balancing devices, pressure sensors, accelerometer-based navigation, optical tracking, and intraoperative analytics can provide information without requiring a full robotic installation. These technologies are particularly relevant to ASCs and smaller hospitals seeking digital capability with limited capital expenditure.

Artificial intelligence will increasingly support preoperative segmentation, implant sizing, surgical planning, operating-room scheduling, risk stratification, and outcome prediction. AI is unlikely to replace surgical judgment, but it can reduce manual planning work, identify patterns across large procedural datasets, and help standardize decision support. The strongest commercial opportunities will emerge where software is integrated with established implants and clinical workflows rather than sold as an isolated analytical tool.

Manufacturers are also raising the bar through evidence generation. Joint replacement procurement increasingly considers registry survivorship, patient-reported outcomes, revision rates, infection data, real-world performance, and economic analysis. Companies with strong registry performance and transparent post-market surveillance can defend premium positioning more effectively than companies relying primarily on design claims.

 

Segmentation Insights

The U.S. Joint Replacement Devices Market is segmented on the basis of product category, joint type, procedure type, end user, and technology type.

 

By Product Category

Joint Replacement Implants

Joint replacement implants represent the largest share of the market. The category includes primary and revision components for the knee, hip, shoulder, ankle, elbow, wrist, and other reconstructive applications. Implant revenue is supported by procedure volume, premium materials, modularity, revision complexity, and the number of components used in each case.

Knee implants include femoral components, tibial trays, polyethylene inserts, patellar components, stems, augments, cones, sleeves, and unicompartmental systems. Hip implants include femoral stems, acetabular cups, liners, femoral heads, dual-mobility constructs, revision shells, cages, augments, and modular reconstruction components. Shoulder products include anatomic and reverse systems, glenoid components, baseplates, humeral stems, stemless designs, and patient-specific guides.

Procedure-Specific Instruments

Procedure-specific instruments include cutting blocks, reamers, broaches, impactors, trials, alignment guides, extraction tools, revision instruments, and reusable or disposable preparation devices. Instruments may not always generate separate implant-like revenue, but they are strategically important because instrument availability, tray complexity, sterilization requirements, and maintenance costs influence vendor selection.

Instrument reduction is becoming a major procurement priority in outpatient settings. Systems that reduce the number of trays per procedure can lower sterilization expense, decrease room turnover time, simplify logistics, and reduce the risk of missing or damaged instruments.

Fixation Materials and Surgical Accessories

This segment includes bone cement, antibiotic-loaded cement, cement mixing and delivery systems, cement restrictors, plugs, screws, sleeves, porous augments, trial components, disposable drapes, lavage systems, and other procedure-linked accessories. Revenue is recurring and closely tied to procedure volume.

Demand for antibiotic-loaded cement and infection-management accessories is supported by the high clinical and financial burden of periprosthetic joint infection. Cementless adoption may moderate conventional cement use in selected primary procedures, but revision arthroplasty and complex fixation continue to support the category.

Robotic and Navigation Enabling Systems

Robotic systems, navigation platforms, handheld guidance technologies, planning software, optical trackers, sensors, service contracts, and procedure-specific disposables represent the fastest-growing product category. Revenue may be generated through direct capital sales, leasing, implant-commitment agreements, per-procedure charges, service contracts, or enterprise partnerships.

The category is becoming more competitive as vendors pursue different price points and facility types. Large hospital networks may prefer multi-application platforms and enterprise analytics, while ASCs may prioritize compact systems, rapid setup, lower service requirements, and image-free workflows.

Patient-Specific and Custom Devices

Patient-specific products include custom implants, custom cutting guides, three-dimensional printed augments, custom triflange acetabular components, oncologic reconstruction devices, and anatomy-matched implants. The category is relatively small by procedure volume but commands high value because it addresses cases that cannot be optimally treated with standard inventories.

 

By Joint Type

Knee Replacement Devices

Knee replacement devices constitute the largest joint-type segment. Demand includes total knee arthroplasty, partial knee replacement, patellofemoral replacement, revision knee arthroplasty, and complex reconstruction. Growth is supported by osteoarthritis prevalence, obesity, aging, expanding outpatient eligibility, and robotic-assisted surgery.

The knee segment is one of the most competitive areas in medical devices. Manufacturers differentiate through implant geometry, bearing design, alignment philosophy, instrumentation, cementless fixation, robotic compatibility, and registry evidence. Partial knee replacement is a smaller but strategically attractive category because it preserves healthy bone and tissue in appropriately selected patients.

Hip Replacement Devices

Hip replacement is the second-largest segment and includes primary total hip replacement, hemiarthroplasty, revision hip replacement, resurfacing, and fracture-related reconstruction. Demand is supported by osteoarthritis, femoral neck fracture, avascular necrosis, developmental abnormalities, and failure of previous implants.

Dual-mobility constructs are receiving greater attention for patients at risk of instability. Cementless stems and cups are widely used, while cemented fixation remains important for selected patients with poor bone quality and for certain fracture indications. Revision hip systems generate premium revenue because they frequently require modular stems, augments, cages, custom components, and specialized extraction tools.

Shoulder Replacement Devices

Shoulder replacement is expected to record above-average growth. The segment includes anatomic total shoulder replacement, reverse shoulder replacement, hemiarthroplasty, resurfacing, and revision systems. Reverse shoulder arthroplasty is a primary growth engine because it expands treatment options for rotator-cuff-deficient shoulders, complex fractures, failed prior surgery, and severe degenerative disease.

Three-dimensional planning, augmented glenoid components, convertible systems, navigation, and stemless designs are increasing the strategic value of the shoulder category. Manufacturers with strong surgeon education and planning capabilities can build differentiated positions even without the scale of the leading hip and knee suppliers.

Ankle Replacement Devices

Total ankle replacement remains a smaller but fast-growing segment. The technology is intended to preserve motion in selected patients with end-stage ankle arthritis. Growth is supported by improved implants, better instrumentation, specialist training, and increasing interest in alternatives to ankle fusion.

The segment requires a specialized commercial model because procedure volumes are concentrated among trained foot and ankle surgeons. Vendor success depends on surgeon education, revision support, imaging, alignment tools, and complementary foot and ankle portfolios.

Elbow, Wrist, and Other Joint Replacement Devices

Elbow, wrist, finger, temporomandibular, oncologic, and other specialized joint replacements form a smaller revenue segment. Procedures are less frequent, but devices can command high value because they address complex trauma, inflammatory disease, tumor reconstruction, severe bone loss, and failed previous surgery.

 

By Procedure Type

Primary Total Joint Replacement

Primary total joint replacement accounts for the largest procedure segment. It includes first-time total knee, hip, shoulder, ankle, elbow, and other joint replacements. Market growth follows the expansion of the eligible patient population, surgeon capacity, facility access, and reimbursement.

The primary segment is highly sensitive to operating-room scheduling, hospital staffing, economic conditions, and patient willingness to undergo elective surgery. It is also the principal target for outpatient pathways, robotics, standardized care protocols, and reduced instrument sets.

Partial and Bone-Preserving Replacement

Partial procedures include unicompartmental knee replacement, patellofemoral replacement, hip resurfacing, shoulder resurfacing, and other bone-preserving approaches. These procedures may offer advantages for selected patients but require accurate indications and surgical execution.

Robotic assistance is expected to support partial knee adoption by improving visualization, planning, component positioning, and procedural reproducibility. DePuy Synthes received FDA clearance in 2024 to expand its VELYS robotic-assisted platform into unicompartmental knee arthroplasty, illustrating the strategic focus on this underpenetrated segment.

Revision Joint Replacement

Revision replacement is expected to grow faster than primary replacement over the long term. Revision procedures are required when an implant fails because of infection, loosening, wear, instability, fracture, malposition, corrosion, or progressive bone loss.

Revision cases generate higher device revenue per procedure because surgeons may require stems, augments, cones, sleeves, cages, constrained components, dual-mobility systems, custom implants, spacers, cement, and specialized extraction tools. Companies with comprehensive revision portfolios can build strong relationships with high-volume referral centers.

Resurfacing and Conversion Procedures

This category includes joint resurfacing and conversion of previous fracture fixation, fusion, hemiarthroplasty, or resurfacing procedures to total joint replacement. Conversion cases can be technically demanding because of altered anatomy, retained hardware, scarring, deformity, and bone loss.

Complex and Oncologic Reconstruction

Complex reconstruction includes megaprostheses, custom implants, total femoral or humeral replacement, pelvic reconstruction, and replacement following tumor resection. Procedure volumes are low, but clinical complexity and high device value make the segment strategically important for specialist suppliers.

 

By End User

Hospitals and Integrated Health Systems

Hospitals and health systems remain the largest end-user segment. They perform the majority of complex primary procedures, revisions, fracture-related replacements, oncologic reconstructions, and cases involving medically complex patients. Large systems frequently negotiate enterprise agreements that cover implants, robotics, service, instruments, training, and data solutions.

Vendor consolidation is common because systems seek to control implant expense, reduce inventory, standardize instruments, and improve purchasing leverage. However, surgeon preference remains influential, particularly when implant systems have established clinical histories or are linked to a preferred robotic platform.

Ambulatory Surgery Centers

ASCs are the fastest-growing end-user segment for appropriately selected primary hip and knee replacements. They prioritize high throughput, predictable recovery, low infection risk, efficient anesthesia, rapid mobilization, compact instrumentation, and disciplined patient selection.

The ASC environment favors vendors that can provide transparent pricing, responsive delivery, limited tray requirements, flexible capital arrangements, and standardized clinical education. Smaller-footprint robotic and navigation technologies are particularly relevant to this segment.

Orthopedic Specialty Hospitals

Orthopedic specialty hospitals generate high procedure concentrations and frequently function as early adopters of advanced implants, robotics, digital planning, and outpatient protocols. Their focused staffing and standardized workflows can support high operating-room productivity and strong patient experience.

Academic and Tertiary Referral Centers

Academic centers are strategically important for clinical trials, complex revisions, infection management, unusual anatomy, custom reconstruction, and surgeon education. These institutions often influence national adoption by producing evidence, training fellows, and participating in registry and guideline development.

Community Hospitals and Regional Orthopedic Centers

Community hospitals represent a large, stable source of primary joint replacement demand. Adoption decisions are shaped by surgeon recruitment, capital budgets, local competition, payer mix, and the ability to transfer medically complex cases to larger centers. Vendors that offer reliable service and scalable technology can expand effectively within this segment.

 

By Technology Type

Conventional Instrumented Joint Replacement

Conventional procedures using mechanical instrumentation remain the largest technology segment. These workflows are familiar, clinically established, and economically accessible. They will continue to represent a substantial share of procedures, particularly where surgeons achieve consistent outcomes without capital-intensive platforms.

Computer-Assisted Navigation

Navigation systems use optical, electromagnetic, accelerometer-based, or other tracking technologies to support alignment and component placement. They can provide digital guidance without the size or cost of a full robotic platform, making them relevant to smaller hospitals and ASCs.

Robotic-Assisted Joint Replacement

Robotic assistance is expected to be the fastest-growing technology segment. Competition now includes robotic-arm platforms, handheld robotic tools, image-based systems, image-free systems, and multi-application platforms. The category will gain share as capital models become more flexible and systems become easier to integrate into outpatient workflows.

Patient-Specific and Three-Dimensional Planning

Patient-specific technology uses CT, MRI, X-ray, or statistical modeling to prepare surgical plans, guides, implants, or custom components. Adoption is strongest in complex shoulder, hip revision, oncologic reconstruction, and unusual anatomical cases.

Sensor-, Data-, and AI-Enabled Arthroplasty

This emerging segment includes smart balancing tools, intraoperative sensors, cloud planning, AI-assisted segmentation, risk analytics, performance dashboards, and connected outcome platforms. Revenue remains smaller than implant or robotic revenue, but the technology will increasingly influence vendor differentiation and value-based contracting.

 

Regional Insights: Where the Market Is Growing Fastest

The U.S. Joint Replacement Devices Market is geographically segmented into the South, West, Northeast, and Midwest. Regional opportunity differs according to population size, age structure, arthritis prevalence, obesity burden, orthopedic surgeon density, ASC penetration, health-system concentration, payer mix, and access to advanced joint replacement programs.

The South represented an estimated USD 4.65 billion in 2025, followed by the West at USD 3.05 billion, the Northeast at USD 2.92 billion, and the Midwest at USD 2.67 billion. By 2035, the South is forecast to reach approximately USD 9.31 billion, the West USD 6.20 billion, the Northeast USD 5.10 billion, and the Midwest USD 4.15 billion.

South

The South is the largest regional market and accounted for approximately 35.0% of U.S. revenue in 2025. The region includes Texas, Florida, Georgia, North Carolina, South Carolina, Virginia, West Virginia, Maryland, Delaware, Tennessee, Kentucky, Alabama, Mississippi, Louisiana, Arkansas, Oklahoma, and the District of Columbia.

Regional demand is supported by large population centers, rapid in-migration, expanding older-adult populations, high obesity prevalence, growing hospital networks, and significant investment in orthopedic ASCs. The South recorded one of the country’s highest regional adult obesity rates in 2024 at approximately 34.5%, reinforcing the long-term burden of weight-related musculoskeletal disease.

Texas is the largest state market in the region. Houston, Dallas-Fort Worth, Austin, and San Antonio support extensive networks of academic hospitals, integrated health systems, orthopedic groups, and ambulatory surgery centers. The state is attractive for implant and robotic suppliers because it combines population growth, commercial insurance, Medicare volume, physician investment, and strong competition among health systems.

Florida is another critical market because of its large older-adult population and substantial Medicare exposure. Demand is particularly strong for hip, knee, and shoulder replacement, revision surgery, fracture-related hip reconstruction, and outpatient arthroplasty. South Florida, Tampa Bay, Orlando, Jacksonville, and the Gulf Coast provide major clusters of orthopedic procedure volume.

North Carolina, Georgia, Tennessee, and Virginia are high-growth markets. These states benefit from expanding metropolitan areas, destination medical centers, growing physician-owned ASC networks, and strong academic orthopedic programs. North Carolina’s Research Triangle, Charlotte, and major western health systems support advanced orthopedic adoption. Georgia’s Atlanta market is a major commercial center, while Tennessee has strong orthopedic networks in Nashville, Memphis, Knoxville, and Chattanooga.

South Carolina is benefiting from population growth and a rapidly expanding older population in coastal and retirement-oriented communities. Maryland and the District of Columbia have sophisticated academic and federal healthcare ecosystems. Delaware is smaller but benefits from proximity to major Mid-Atlantic referral markets.

Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, and West Virginia have substantial arthritis, obesity, and chronic disease burdens. These states represent meaningful demand for conventional hip and knee systems, revision implants, and cost-efficient hospital solutions. Rural access, surgeon availability, transportation, and post-acute capacity can constrain adoption of premium technology outside metropolitan centers.

The South is projected to reach USD 9.31 billion by 2035, reflecting a regional CAGR of approximately 7.19%. Growth will be driven by population expansion, ASC development, robotic adoption, cementless knee replacement, shoulder arthroplasty, and the replacement needs of an aging population.

West

The West is expected to record the fastest regional growth, increasing from approximately USD 3.05 billion in 2025 to USD 6.20 billion by 2035, representing a CAGR of about 7.35%. The region includes California, Washington, Oregon, Arizona, Nevada, Colorado, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii.

California is the largest state market in the West and one of the most important joint replacement markets nationally. It combines a large population, major academic institutions, sophisticated integrated delivery networks, a strong commercial insurance base, and significant medtech innovation. Los Angeles, San Diego, the Bay Area, Sacramento, and Orange County support high procedure volumes and early adoption of robotics, data analytics, patient-specific planning, and outpatient surgery.

California’s health-system market is highly consolidated in several areas, which can accelerate enterprise standardization but also intensify pricing pressure. Manufacturers seeking adoption must demonstrate clinical differentiation, service reliability, supply-chain continuity, and measurable economic value.

Arizona and Nevada are among the fastest-growing state opportunities because of population migration, retirement communities, and expanding hospital infrastructure. Phoenix, Tucson, Las Vegas, and Reno are important markets for primary hip and knee replacement, robotic-assisted procedures, and outpatient joint programs.

Colorado and Utah combine younger active populations with expanding older-adult groups and sophisticated orthopedic care. Denver, Colorado Springs, Salt Lake City, and surrounding markets support advanced sports medicine and joint reconstruction programs. Providers in these states frequently emphasize rapid recovery, patient mobility, and return to outdoor activity.

Washington and Oregon have strong integrated health systems and evidence-oriented procurement environments. Seattle, Spokane, Portland, and Eugene support demand for premium implants, complex revision systems, shoulder replacement, and digital planning. These markets may require stronger health-economic evidence and enterprise integration than fragmented physician-preference markets.

New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii are smaller device markets but create specialized logistics and access requirements. Regional referral networks, inventory availability, air transportation, and field support can be decisive. Compact instrument sets and reliable distributor coverage are especially valuable in remote areas.

The West will gain market share through robotics, patient-specific implants, outpatient care, shoulder replacement, total ankle replacement, and data-enabled orthopedic pathways.

Northeast

The Northeast accounted for approximately USD 2.92 billion in 2025 and is projected to reach USD 5.10 billion by 2035, representing a CAGR of approximately 5.73%. The region includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Rhode Island, Maine, Vermont, and New Hampshire.

New York is the region’s largest state market. New York City, Long Island, Westchester, Albany, Rochester, Syracuse, and Buffalo support extensive hospital and orthopedic networks. The state contains internationally recognized joint replacement centers, high-volume surgeons, complex revision programs, and influential academic institutions.

Pennsylvania and New Jersey provide large and commercially important procedure bases. Philadelphia, Pittsburgh, central Pennsylvania, northern New Jersey, and the New York metropolitan corridor support high-volume primary and revision arthroplasty. New Jersey also has a strong outpatient and physician-practice environment, although regulatory and ownership structures influence ASC development.

Massachusetts has a smaller population than New York or Pennsylvania but exerts disproportionate influence through academic medicine, research, clinical trials, and technology evaluation. Boston-based institutions frequently participate in evidence generation, complex reconstruction, and early adoption of advanced planning systems.

Connecticut and Rhode Island support concentrated orthopedic markets with close proximity to Boston and New York. Maine, Vermont, and New Hampshire have older populations and meaningful replacement demand but lower absolute procedure volumes. Rural geography and limited specialist availability create opportunities for regional referral programs, efficient implant logistics, and telehealth-supported pre- and postoperative care.

The Northeast is a mature market with strong implant penetration. Growth will therefore depend less on basic access expansion and more on revision procedures, robotic upgrades, complex reconstruction, shoulder replacement, infection management, and premium technology adoption.

Midwest

The Midwest represented approximately USD 2.67 billion in 2025 and is expected to reach USD 4.15 billion by 2035, reflecting a CAGR of approximately 4.51%. The region includes Illinois, Ohio, Michigan, Indiana, Wisconsin, Minnesota, Missouri, Iowa, Kansas, Nebraska, North Dakota, and South Dakota.

Illinois is the largest regional state market, supported by Chicago’s extensive academic, community, and suburban healthcare infrastructure. The state provides strong demand for primary joint replacement, complex revision, orthopedic robotics, and ASC-based procedures.

Ohio has major orthopedic markets in Cleveland, Columbus, Cincinnati, Dayton, and Toledo. Its large hospital systems and established joint programs make it strategically important for enterprise contracting and clinical education. Michigan supports substantial knee, hip, and shoulder demand through Detroit, Grand Rapids, Ann Arbor, and regional community networks.

Minnesota is influential because of its medtech ecosystem, orthopedic expertise, and sophisticated healthcare institutions. Wisconsin and Indiana provide stable procedure volume and growing outpatient adoption. Missouri supports important markets in St. Louis, Kansas City, Springfield, and surrounding referral areas.

Iowa, Kansas, Nebraska, North Dakota, and South Dakota are smaller markets characterized by regional referral centers and broad rural catchment areas. Supplier performance depends on field coverage, implant availability, responsive technical support, and the ability to serve hospitals with lower annual procedure volumes.

The Midwest’s adult obesity prevalence reached approximately 35.9% in 2024, the highest among the four U.S. regions. This contributes to a substantial long-term musculoskeletal burden, although slower population growth and mature hospital markets are expected to keep revenue growth below the South and West.

 

Key Market Players

The U.S. Joint Replacement Devices Competitive Landscape is highly consolidated in primary hip and knee replacement, while shoulder, ankle, custom reconstruction, robotics, and patient-specific devices support a broader group of specialized competitors.

Major competitors are increasingly building integrated orthopedic ecosystems rather than competing through individual implants. Their offerings combine primary and revision implants, robotics, navigation, digital planning, instruments, service contracts, surgeon training, ASC solutions, and outcomes analytics. Broad portfolio companies can negotiate enterprise agreements across multiple facilities, while specialist companies can gain share by addressing underpenetrated joints or complex clinical needs.

Some of the key players operating in the U.S. Joint Replacement Devices industry are Stryker Corporation, Zimmer Biomet Holdings, DePuy Synthes of Johnson & Johnson MedTech, Smith+Nephew, Enovis Corporation, Exactech, MicroPort Orthopedics, Corin Group, Medacta International, United Orthopedic Corporation, Aesculap–B. Braun, restor3d, Conformis, THINK Surgical, OrthAlign, Monogram Technologies, Maxx Orthopedics, Kinamed, Waldemar LINK, Heraeus Medical, SINTX Technologies, Onkos Surgical, Catalyst Orthoscience, Shoulder Innovations, and Paragon 28 within Zimmer Biomet.

Stryker, Zimmer Biomet, DePuy Synthes, and Smith+Nephew hold particularly strong positions because they combine established hip and knee implants with robotic or digital surgery platforms. Zimmer Biomet expanded its extremities portfolio through the approximately USD 1.2 billion acquisition of Paragon 28, completed in April 2025.

Enovis has strengthened its reconstruction portfolio through orthopedic platform expansion and the integration of LimaCorporate. Exactech remains relevant across knee, hip, shoulder, and ankle replacement but has faced significant commercial and reputational pressure related to recalled polyethylene-containing joint replacement devices.

Medacta, MicroPort Orthopedics, Corin, United Orthopedic, and Maxx Orthopedics compete through implant design, surgeon relationships, service, and selected enabling technologies. restor3d and Conformis are positioned around patient-specific and additively manufactured solutions. Catalyst Orthoscience and Shoulder Innovations focus on the growing shoulder replacement market.

THINK Surgical, OrthAlign, and Monogram Technologies represent the expanding enabling-technology layer. These companies compete through robotics, navigation, personalization, and alternative capital models that may allow hospitals or ASCs to obtain digital capability without committing exclusively to a traditional implant manufacturer.

Market share through 2035 will be influenced by implant survivorship, robotic-platform utilization, outpatient compatibility, revision breadth, supply-chain reliability, surgeon conversion, service quality, FDA clearances, registry performance, and the ability to support value-based episodes. Manufacturers that can demonstrate lower instrument burden, predictable procedure times, reduced complications, and stronger patient-reported outcomes will be best positioned to protect premium pricing.

 

Recent Developments

Recent developments demonstrate that the U.S. joint replacement devices market is entering a new cycle of robotic competition, portfolio consolidation, regulatory scrutiny, and value-based reimbursement.

In June 2024, DePuy Synthes received FDA 510(k) clearance to use the VELYS Robotic-Assisted Solution in unicompartmental knee arthroplasty. At the time of the announcement, the broader VELYS platform had been used in more than 55,000 procedures. The expanded indication is strategically important because robotics may reduce technical barriers to partial knee replacement and support adoption in ambulatory surgery centers.

During 2024, the FDA continued to communicate risks associated with certain Exactech hip, knee, ankle, and shoulder replacement devices. The affected products had been packaged in bags lacking an oxygen-barrier layer, creating a risk of polyethylene oxidation, accelerated wear, component damage, bone loss, and revision surgery. The issue reinforced the importance of packaging validation, post-market surveillance, implant traceability, and long-term patient monitoring.

In April 2025, Zimmer Biomet completed its acquisition of Paragon 28. The transaction expanded Zimmer Biomet’s presence in foot and ankle reconstruction, including total ankle replacement, and created opportunities to combine Paragon 28’s specialist commercial channel with Zimmer Biomet’s broader hospital, ASC, and enabling-technology capabilities.

In November 2025, Zimmer Biomet received FDA clearance for ROSA Knee with OptimiZe. The enhanced platform introduced personalized planning, tracking, landmarking, kinematic alignment, and user-interface capabilities. U.S. commercial availability was expected during the first quarter of 2026, strengthening competition in data-driven robotic knee replacement.

In June 2026, Smith+Nephew announced the first clinical cases using its next-generation CORI XT handheld robotics platform across knee and shoulder arthroplasty. The inclusion of shoulder applications demonstrates how orthopedic robotics is expanding beyond its initial concentration in total knee and total hip replacement.

In July 2026, Stryker announced the U.S. commercial launch of Mako RPS for total knee replacement. The handheld robotic power system combines intraoperative planning with robotically enabled cutting and is intended to extend the Mako ecosystem to a broader range of orthopedic customers and care settings.

Reimbursement is also entering a new phase. CMS has announced that the nationwide mandatory CJR-X episode-payment model will begin on October 1, 2027. Hospitals participating in the model will be evaluated on spending and quality across the joint replacement procedure and 90-day recovery period. This change is likely to increase demand for standardized clinical pathways, patient-reported outcome collection, coordinated rehabilitation, and devices that support predictable episode economics.

 

Conclusion

The U.S. Joint Replacement Devices Market Size & Share is positioned for sustained expansion from USD 13.29 billion in 2025 to USD 24.76 billion by 2035, supported by a 6.42% CAGR during the forecast period 2026–2035.

The market’s long-term resilience is grounded in arthritis prevalence, growth of the older-adult population, increasing primary and revision procedure volumes, outpatient migration, and high patient demand for mobility and independence. Hip and knee implants will continue to generate most revenue, but faster percentage growth is expected in robotic enabling systems, patient-specific reconstruction, shoulder replacement, total ankle replacement, revision implants, and data-supported orthopedic workflows.

Hospitals and orthopedic groups will increasingly evaluate suppliers through total episode economics. Implant price will remain important, but purchasing decisions will also reflect instrument processing, robotic utilization, operating-room efficiency, implant survivorship, complications, post-acute utilization, readmissions, and patient-reported outcomes. The nationwide introduction of CJR-X from October 2027 will accelerate this transition toward accountable joint replacement episodes.

The South will remain the largest regional market because of population scale, older-adult growth, obesity burden, and expansion of hospital and ASC networks. The West will record the fastest growth through technology adoption, population migration, and outpatient care. The Northeast will remain a premium market for complex reconstruction and evidence generation, while the Midwest will provide a stable base of mature procedure demand.

Texas, Florida, California, New York, Pennsylvania, Illinois, Ohio, New Jersey, North Carolina, Georgia, Arizona, Michigan, Massachusetts, Tennessee, Virginia, Minnesota, Washington, and Colorado will be among the most strategically important state markets. However, underserved and rural states will also present opportunities for streamlined instrumentation, mobile service models, regional referral partnerships, and compact enabling technologies.

For clients evaluating the market, the central question is not simply how many joint replacements will be performed. The more important issue is how value will migrate between conventional implants, advanced materials, revision systems, robotics, digital planning, outpatient solutions, and outcome-enabled platforms.

Companies that combine durable implants with efficient workflows, strong registry evidence, broad revision capability, outpatient compatibility, and flexible technology models will define the next decade of the U.S. joint replacement devices industry.

 

TABLE OF CONTENT

1. U.S. Joint Replacement Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Market-Sizing Frameworks & Forecasting Models
1.3.6. Data Triangulation, Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Joint Replacement Implant Manufacturers
1.6.2. Robotic Surgery, Navigation and Digital Planning Companies
1.6.3. Biomaterial, Component and Contract Manufacturing Suppliers
1.6.4. Hospitals and Integrated Delivery Networks
1.6.5. Orthopedic Specialty Hospitals and Ambulatory Surgery Centers
1.6.6. Orthopedic Surgeons and Physician-Owned Practices
1.6.7. Group Purchasing Organizations, Distributors and Logistics Providers
1.6.8. Payers, Regulators and Clinical Decision-Makers

What this section provides: This section defines the market boundary, study scope, methodology, assumptions, device inclusions, exclusions, and stakeholder ecosystem so clients understand how the U.S. joint replacement devices market is measured and validated.

2. U.S. Joint Replacement Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. High-Growth Opportunity Areas
2.8. Leading Joint Replacement Procedure Categories
2.9. Outpatient Arthroplasty and Robotic Surgery Snapshot
2.10. Key Strategic Findings for Manufacturers and Investors

What this section provides: This section gives decision-makers a concise view of market size, historical performance, forecast growth, procedure trends, competitive intensity, technology adoption, and priority commercial opportunities.

3. U.S. Joint Replacement Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising Prevalence of Osteoarthritis and Degenerative Joint Disease
3.1.2. Expansion of the U.S. Population Aged 65 Years and Older
3.1.3. Increasing Primary Hip and Knee Replacement Procedure Volumes
3.1.4. Growth in Revision and Complex Reconstruction Procedures
3.1.5. Migration of Joint Replacement Procedures to Outpatient Settings
3.1.6. Adoption of Robotic-Assisted and Digitally Planned Arthroplasty
3.1.7. Increasing Demand for Cementless and Advanced-Fixation Implants
3.1.8. Patient Preference for Mobility, Independence and Faster Recovery
3.2. Restraints and Their Impact Analysis
3.2.1. High Implant, Robotic Platform and Procedure Costs
3.2.2. Hospital Price Pressure and Vendor Standardization
3.2.3. Product Recalls, Litigation and Implant Safety Concerns
3.2.4. Reimbursement Pressure and Bundled-Payment Exposure
3.2.5. Infection, Readmission and Revision Surgery Risks
3.2.6. Uneven Access to Advanced Orthopedic Care
3.3. Opportunities and Their Impact Analysis
3.3.1. Ambulatory Surgery Center-Specific Implant and Instrument Platforms
3.3.2. Expansion of Robotic and Navigation Technology Penetration
3.3.3. Growth in Shoulder and Ankle Replacement Procedures
3.3.4. Patient-Specific and Three-Dimensional Printed Implants
3.3.5. Cementless Knee and Advanced Porous-Fixation Systems
3.3.6. Complex Revision and Periprosthetic Joint Infection Solutions
3.3.7. Value-Based Joint Replacement and CJR-X Preparedness
3.3.8. Digital Recovery Monitoring and Patient-Reported Outcomes
3.4. Challenges and Their Impact Analysis
3.4.1. Surgeon Conversion and Training Requirements
3.4.2. Robotic Platform Utilization and Capital Return-on-Investment Risk
3.4.3. Instrument Inventory and Sterile Processing Complexity
3.4.4. Long-Term Evidence Requirements for New Implant Technologies
3.4.5. Supply-Chain Continuity and Component Availability
3.4.6. Data Integration Across Surgical and Recovery Workflows
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.6.1. Operating-Room Time and Turnover Economics
3.6.2. Instrument Tray and Sterile Processing Economics
3.6.3. Inpatient Versus Outpatient Episode Economics
3.6.4. Post-Acute Care, Readmission and Revision Cost Burden
3.7. Hospital Capital Procurement Behavior Analysis
3.7.1. Implant Vendor Selection Criteria
3.7.2. Robotic System Capital Approval Framework
3.7.3. Surgeon Preference Versus Enterprise Standardization
3.7.4. Implant Commitment and Capital Placement Agreements
3.7.5. Total Episode Cost and Value Analysis Committee Review

What this section provides: This section explains the demographic, clinical, reimbursement, technological, operational, and procurement forces shaping joint replacement demand, helping clients evaluate growth potential and execution risk.

4. U.S. Joint Replacement Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Hospitals and Orthopedic Buyers
4.2.3. Bargaining Power of Component and Biomaterial Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Joint Replacement Implant Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.4.1. Raw Materials and Medical-Grade Alloys
4.4.2. Implant Design and Engineering
4.4.3. Contract Manufacturing and Precision Machining
4.4.4. Sterilization and Packaging
4.4.5. Distribution, Consignment and Inventory Management
4.4.6. Hospitals, ASCs and Orthopedic Care Providers
4.5. Impact of Digitalization on Joint Replacement Workflows
4.6. Application & Innovation Landscape
4.7. FDA Regulatory Framework Analysis
4.7.1. Premarket Notification and 510(k) Pathways
4.7.2. Premarket Approval and De Novo Considerations
4.7.3. Post-Market Surveillance and Medical Device Reporting
4.7.4. Implant Recall and Safety Communication Framework
4.8. CMS Reimbursement and Coverage Landscape
4.8.1. Inpatient Joint Replacement Reimbursement
4.8.2. Hospital Outpatient Reimbursement
4.8.3. Ambulatory Surgery Center Reimbursement
4.8.4. Bundled Payments and CJR-X Model Implications
4.9. Import/Export Restrictions & Tariff Impact
4.10. Government Initiatives and Musculoskeletal Health Programs
4.11. Impact of Escalating Geopolitical Tensions
4.12. Hospital Value Analysis Committee Decision Framework
4.12.1. Clinical Evidence and Implant Survivorship
4.12.2. Surgeon Demand and Training Requirements
4.12.3. Implant Price and Procedure Cost
4.12.4. Instrumentation and Sterile Processing Burden
4.12.5. Robotic Platform Compatibility
4.12.6. Supply Reliability and Field Support
4.12.7. Patient-Reported Outcomes and Revision Risk

What this section provides: This section gives clients a complete view of the external market environment, including regulation, reimbursement, implant pricing, supply chains, digital technology, hospital procurement, and competitive operating conditions.

5. U.S. Joint Replacement Devices Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.1.2. Segment Market Size and Forecast, 2021–2035 (US$ Billion)
5.2. Joint Replacement Implants
5.2.1. Primary Joint Replacement Implants
5.2.2. Revision Joint Replacement Implants
5.2.3. Modular Augments, Cones, Sleeves and Stems
5.2.4. Dual-Mobility and Constrained Components
5.2.5. Custom and Megaprosthetic Reconstruction Systems
5.3. Procedure-Specific Instruments
5.3.1. Cutting and Bone Preparation Instruments
5.3.2. Reamers, Broaches and Impactors
5.3.3. Alignment and Positioning Instruments
5.3.4. Trial Components
5.3.5. Revision Extraction Instruments
5.3.6. Reduced-Tray and Disposable Instrument Systems
5.4. Fixation Materials and Surgical Accessories
5.4.1. Standard Bone Cement
5.4.2. Antibiotic-Loaded Bone Cement
5.4.3. Cement Mixing and Delivery Systems
5.4.4. Screws, Plugs and Fixation Accessories
5.4.5. Porous Augments and Bone Defect Solutions
5.4.6. Lavage and Procedure-Linked Accessories
5.5. Robotic and Navigation Enabling Systems
5.5.1. Robotic-Arm Surgical Platforms
5.5.2. Handheld Robotic Systems
5.5.3. Computer-Assisted Navigation Systems
5.5.4. Optical and Sensor-Based Tracking Systems
5.5.5. Preoperative Planning Software
5.5.6. Service Contracts and Procedure-Specific Disposables
5.6. Patient-Specific and Custom Devices
5.6.1. Patient-Specific Cutting Guides
5.6.2. Custom Joint Replacement Implants
5.6.3. Three-Dimensional Printed Porous Implants
5.6.4. Custom Triflange Acetabular Components
5.6.5. Oncologic and Severe Bone-Loss Reconstruction Devices

What this section provides: This section identifies the product categories expected to generate the largest revenue contribution and strongest growth, including implants, instruments, fixation products, robotic systems, and customized reconstruction devices.

6. U.S. Joint Replacement Devices Market – By Joint Type

6.1. Overview
6.1.1. Segment Share Analysis, By Joint Type, 2025 & 2035 (%)
6.1.2. Segment Market Size and Forecast, 2021–2035 (US$ Billion)
6.2. Knee Replacement Devices
6.2.1. Total Knee Replacement Devices
6.2.2. Unicompartmental Knee Replacement Devices
6.2.3. Patellofemoral Replacement Devices
6.2.4. Revision Knee Replacement Devices
6.2.5. Cemented Knee Systems
6.2.6. Cementless Knee Systems
6.3. Hip Replacement Devices
6.3.1. Total Hip Replacement Devices
6.3.2. Partial Hip and Hemiarthroplasty Devices
6.3.3. Hip Resurfacing Devices
6.3.4. Revision Hip Replacement Devices
6.3.5. Dual-Mobility Hip Systems
6.3.6. Cemented and Cementless Hip Systems
6.4. Shoulder Replacement Devices
6.4.1. Anatomic Total Shoulder Replacement Devices
6.4.2. Reverse Shoulder Replacement Devices
6.4.3. Shoulder Hemiarthroplasty Devices
6.4.4. Stemless Shoulder Replacement Devices
6.4.5. Revision Shoulder Replacement Devices
6.5. Ankle Replacement Devices
6.5.1. Fixed-Bearing Ankle Replacement Devices
6.5.2. Mobile-Bearing Ankle Replacement Devices
6.5.3. Revision Ankle Replacement Devices
6.6. Elbow, Wrist and Other Joint Replacement Devices
6.6.1. Elbow Replacement Devices
6.6.2. Wrist Replacement Devices
6.6.3. Finger Joint Replacement Devices
6.6.4. Temporomandibular Joint Replacement Devices
6.6.5. Oncologic and Specialty Joint Reconstruction Devices

What this section provides: This section evaluates demand by anatomical joint and helps clients compare procedure volume, implant value, competitive intensity, innovation potential, and future growth across knee, hip, shoulder, ankle, and specialty joints.

7. U.S. Joint Replacement Devices Market – By Procedure Type

7.1. Overview
7.1.1. Segment Share Analysis, By Procedure Type, 2025 & 2035 (%)
7.1.2. Segment Market Size and Forecast, 2021–2035 (US$ Billion)
7.2. Primary Total Joint Replacement
7.2.1. Primary Total Knee Replacement
7.2.2. Primary Total Hip Replacement
7.2.3. Primary Total Shoulder Replacement
7.2.4. Primary Total Ankle Replacement
7.2.5. Other Primary Total Joint Replacement Procedures
7.3. Partial and Bone-Preserving Joint Replacement
7.3.1. Unicompartmental Knee Replacement
7.3.2. Patellofemoral Replacement
7.3.3. Hip Resurfacing
7.3.4. Shoulder Resurfacing
7.3.5. Other Bone-Preserving Procedures
7.4. Revision Joint Replacement
7.4.1. Revision Knee Replacement
7.4.2. Revision Hip Replacement
7.4.3. Revision Shoulder Replacement
7.4.4. Revision Ankle Replacement
7.4.5. Revision for Periprosthetic Joint Infection
7.4.6. Revision for Aseptic Loosening, Wear and Instability
7.5. Resurfacing and Conversion Procedures
7.5.1. Conversion of Prior Fracture Fixation
7.5.2. Conversion of Hemiarthroplasty
7.5.3. Conversion of Joint Fusion
7.5.4. Conversion of Prior Resurfacing Procedures
7.6. Complex and Oncologic Reconstruction
7.6.1. Megaprosthetic Reconstruction
7.6.2. Custom Pelvic Reconstruction
7.6.3. Total Femoral Replacement
7.6.4. Total Humeral Replacement
7.6.5. Post-Tumor Resection Joint Reconstruction

What this section provides: This section explains revenue and demand by procedure type, allowing clients to distinguish high-volume primary procedures from faster-growing revision, conversion, and complex reconstruction opportunities.

8. U.S. Joint Replacement Devices Market – By End User

8.1. Overview
8.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
8.1.2. Segment Market Size and Forecast, 2021–2035 (US$ Billion)
8.2. Hospitals and Integrated Health Systems
8.2.1. Large Integrated Delivery Networks
8.2.2. General Acute-Care Hospitals
8.2.3. Hospital Outpatient Departments
8.2.4. Health System-Owned Orthopedic Centers
8.3. Ambulatory Surgery Centers
8.3.1. Independent Multispecialty ASCs
8.3.2. Orthopedic-Focused ASCs
8.3.3. Hospital–Physician Joint-Venture ASCs
8.3.4. Physician-Owned ASCs
8.4. Orthopedic Specialty Hospitals
8.4.1. Independent Orthopedic Hospitals
8.4.2. Health System-Affiliated Orthopedic Hospitals
8.4.3. High-Volume Joint Replacement Centers
8.5. Academic and Tertiary Referral Centers
8.5.1. Academic Medical Centers
8.5.2. Complex Revision Referral Centers
8.5.3. Musculoskeletal Research and Teaching Institutions
8.5.4. Oncologic Reconstruction Centers
8.6. Community Hospitals and Regional Orthopedic Centers
8.6.1. Community-Based Joint Replacement Programs
8.6.2. Rural Referral Hospitals
8.6.3. Regional Orthopedic Networks

What this section provides: This section explains which care settings are expected to drive implant purchasing, robotic adoption, outpatient migration, complex revision demand, and enterprise-level supplier contracting.

9. U.S. Joint Replacement Devices Market – By Technology Type

9.1. Overview
9.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
9.1.2. Segment Market Size and Forecast, 2021–2035 (US$ Billion)
9.2. Conventional Instrumented Joint Replacement
9.2.1. Mechanical Alignment Instrumentation
9.2.2. Conventional Cutting Guides and Jigs
9.2.3. Standard Reusable Instrument Systems
9.2.4. Conventional Cemented Implant Workflows
9.3. Computer-Assisted Navigation
9.3.1. Optical Navigation
9.3.2. Electromagnetic Navigation
9.3.3. Accelerometer-Based Navigation
9.3.4. Image-Based Navigation
9.3.5. Image-Free Navigation
9.4. Robotic-Assisted Joint Replacement
9.4.1. Robotic-Arm Systems
9.4.2. Handheld Robotic Systems
9.4.3. Image-Based Robotic Systems
9.4.4. Image-Free Robotic Systems
9.4.5. Multi-Joint Robotic Platforms
9.5. Patient-Specific and Three-Dimensional Planning
9.5.1. CT-Based Surgical Planning
9.5.2. MRI-Based Surgical Planning
9.5.3. X-Ray-Based Digital Planning
9.5.4. Patient-Specific Instrumentation
9.5.5. Customized and Three-Dimensional Printed Implants
9.6. Sensor-, Data- and AI-Enabled Arthroplasty
9.6.1. Intraoperative Pressure and Balance Sensors
9.6.2. Smart Alignment and Positioning Instruments
9.6.3. AI-Assisted Implant Sizing and Planning
9.6.4. Surgical Performance Analytics
9.6.5. Patient-Reported Outcome Platforms
9.6.6. Connected Recovery and Remote Monitoring Tools

What this section provides: This section evaluates the technologies reshaping joint replacement, ranging from conventional instrumentation to navigation, robotics, patient-specific planning, intraoperative sensors, analytics, and AI-supported workflows.

10. U.S. Joint Replacement Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Joint Replacement Procedure Volume Analysis
10.1.4. Regional Hospital, Orthopedic Center and ASC Infrastructure Analysis
10.1.5. Regional Demographic and Arthritis Burden Analysis
10.1.6. Regional Reimbursement and Procurement Dynamics
10.1.7. Regional Robotic Surgery and Outpatient Adoption Analysis

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Joint Replacement Device Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Joint Replacement Device Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Joint Replacement Device Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Joint Replacement Device Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Joint Type, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level analysis for all 50 states, helping clients identify priority geographies, procedure-volume hubs, demographic demand pockets, outpatient adoption centers, robotic surgery hotspots, and state-level commercial opportunities.

11. U.S. Joint Replacement Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.1.1. Overall Joint Replacement Device Market Share
11.1.2. Knee Replacement Device Market Share
11.1.3. Hip Replacement Device Market Share
11.1.4. Shoulder Replacement Device Market Share
11.1.5. Robotic and Navigation Platform Market Share
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Company Profiles
11.3.1. Stryker Corporation
11.3.2. Zimmer Biomet Holdings, Inc.
11.3.3. DePuy Synthes – Johnson & Johnson MedTech
11.3.4. Smith+Nephew
11.3.5. Enovis Corporation
11.3.6. Exactech, Inc.
11.3.7. MicroPort Orthopedics Inc.
11.3.8. Corin Group
11.3.9. Medacta International
11.3.10. United Orthopedic Corporation
11.3.11. Aesculap, Inc. – B. Braun
11.3.12. restor3d, Inc.
11.3.13. Conformis, Inc.
11.3.14. THINK Surgical, Inc.
11.3.15. OrthAlign, Inc.
11.3.16. Monogram Technologies Inc.
11.3.17. Maxx Orthopedics, Inc.
11.3.18. Kinamed Incorporated
11.3.19. Waldemar LINK GmbH & Co. KG
11.3.20. Heraeus Medical
11.3.21. SINTX Technologies, Inc.
11.3.22. Onkos Surgical
11.3.23. Catalyst Orthoscience Inc.
11.3.24. Shoulder Innovations, Inc.
11.3.25. Paragon 28 – Zimmer Biomet

Note: Each company profile will include company overview, joint replacement portfolio, implant and enabling-technology positioning, U.S. market strategy, financial positioning, clinical evidence, regulatory developments, partnerships, acquisitions, product launches, and recent developments.

What this section provides: This section gives clients competitor benchmarking, market-share visibility, implant portfolio positioning, robotic-platform strategy, innovation direction, acquisition activity, and strategic intelligence on leading joint replacement device companies.

12. U.S. Joint Replacement Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Robotic-Assisted Joint Replacement
12.2.2. AI-Assisted Planning and Personalized Alignment
12.2.3. Patient-Specific and Three-Dimensional Printed Implants
12.2.4. Cementless Fixation and Advanced Porous Materials
12.2.5. Intraoperative Sensors and Smart Instrumentation
12.2.6. Connected Recovery and Patient-Reported Outcome Platforms
12.3. Emerging Business Trends
12.3.1. Implant and Robotic Platform Bundling
12.3.2. Expansion of Physician-Owned Orthopedic ASCs
12.3.3. Enterprise Vendor Standardization
12.3.4. Outcome-Based and Risk-Sharing Agreements
12.3.5. Growth of Specialized Revision and Infection Centers
12.3.6. Shift Toward Reduced-Tray and Disposable Instrumentation
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.5.1. Market Attractiveness
12.5.2. Clinical Unmet Need
12.5.3. Technology Differentiation
12.5.4. Reimbursement Readiness
12.5.5. Competitive Intensity
12.5.6. Commercial Scalability

What this section provides: This section prepares clients for future technology shifts, changing care settings, value-based reimbursement, investment opportunities, competitive disruption, and adoption scenarios through 2035.

13. U.S. Joint Replacement Devices Market: Strategic Recommendations

13.1. Recommendations for Joint Replacement Device Manufacturers
13.1.1. Implant Portfolio Optimization
13.1.2. Revision and Complex Reconstruction Expansion
13.1.3. Robotic and Navigation Ecosystem Development
13.1.4. ASC-Specific Product and Pricing Strategy
13.1.5. Clinical Evidence and Registry Strategy
13.2. Recommendations for Hospitals and Integrated Health Systems
13.2.1. Vendor Standardization Strategy
13.2.2. Robotic Platform Capital Planning
13.2.3. Outpatient Joint Replacement Expansion
13.2.4. CJR-X and Episode-Cost Preparedness
13.3. Recommendations for Orthopedic ASCs and Specialty Hospitals
13.4. Recommendations for Investors and Private Equity Firms
13.5. Recommendations for Distributors and Channel Partners
13.6. Recommendations for New Entrants and Startups
13.7. Go-to-Market Strategy Considerations
13.7.1. Surgeon Education and Conversion
13.7.2. Key Opinion Leader Development
13.7.3. Hospital Value Analysis Engagement
13.7.4. ASC Commercialization Strategy
13.7.5. Distributor Versus Direct-Sales Strategy
13.8. Product Positioning and Portfolio Expansion Guidance

What this section provides: This section converts market intelligence into actionable recommendations for product strategy, capital planning, outpatient expansion, market entry, investment prioritization, channel development, and competitive differentiation.

14. U.S. Joint Replacement Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Legal Disclaimer
14.5. Third-Party Data Disclaimer
14.6. Procedure-Volume Estimation Limitation
14.7. State-Level Market Allocation Limitation
14.8. Regulatory and Reimbursement Change Disclaimer

What this section provides: This section clarifies the report’s market boundaries, methodological limitations, data-use terms, state-level estimation assumptions, forecasting constraints, and legal considerations.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Joint Replacement Devices Market: Market Definition and Scope
TABLE 3: U.S. Joint Replacement Devices Market: Research Methodology Framework
TABLE 4: U.S. Joint Replacement Devices Market: Key Assumptions
TABLE 5: U.S. Joint Replacement Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Joint Replacement Devices Market: Stakeholder Analysis
TABLE 7: U.S. Joint Replacement Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Joint Replacement Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Joint Replacement Devices Market: Market Attractiveness Index
TABLE 10: U.S. Joint Replacement Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Joint Replacement Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Joint Replacement Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Joint Replacement Devices Market: Drivers; Impact Analysis
TABLE 14: U.S. Joint Replacement Devices Market: Restraints; Impact Analysis
TABLE 15: U.S. Joint Replacement Devices Market: Opportunities; Impact Analysis
TABLE 16: U.S. Joint Replacement Devices Market: Challenges; Impact Analysis
TABLE 17: U.S. Joint Replacement Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 18: U.S. Joint Replacement Devices Market: Clinical Workflow Economics Matrix
TABLE 19: U.S. Joint Replacement Devices Market: Hospital Capital Procurement Behavior Matrix
TABLE 20: U.S. Joint Replacement Devices Market: PESTEL Analysis
TABLE 21: U.S. Joint Replacement Devices Market: Porter’s Five Forces Analysis
TABLE 22: U.S. Joint Replacement Devices Market: Implant Pricing Trend Analysis by Region, 2025–2035
TABLE 23: U.S. Joint Replacement Devices Market: Value Chain Analysis
TABLE 24: U.S. Joint Replacement Devices Market: Supply Chain Analysis
TABLE 25: U.S. Joint Replacement Devices Market: Digitalization and Joint Replacement Workflow Impact
TABLE 26: U.S. Joint Replacement Devices Market: Application & Innovation Landscape
TABLE 27: U.S. Joint Replacement Devices Market: FDA Regulatory Framework Analysis
TABLE 28: U.S. Joint Replacement Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 29: U.S. Joint Replacement Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 30: U.S. Joint Replacement Devices Market: Government Initiatives and Musculoskeletal Health Programs
TABLE 31: U.S. Joint Replacement Devices Market: Impact of Escalating Geopolitical Tensions
TABLE 32: U.S. Joint Replacement Devices Market: Hospital Value Analysis Committee Decision Framework
TABLE 33: U.S. Joint Replacement Devices Market: Product Category Snapshot, 2025
TABLE 34: Segment Dashboard; Definition and Scope, by Product Category
TABLE 35: U.S. Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 36: U.S. Joint Replacement Devices Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 37: U.S. Joint Replacement Devices Market: Joint Replacement Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 38: U.S. Joint Replacement Devices Market: Procedure-Specific Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 39: U.S. Joint Replacement Devices Market: Fixation Materials and Surgical Accessories Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 40: U.S. Joint Replacement Devices Market: Robotic and Navigation Enabling Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 41: U.S. Joint Replacement Devices Market: Patient-Specific and Custom Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 42: U.S. Joint Replacement Devices Market: Joint Type Snapshot, 2025
TABLE 43: Segment Dashboard; Definition and Scope, by Joint Type
TABLE 44: U.S. Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 45: U.S. Joint Replacement Devices Market: Segment Share Analysis, by Joint Type, 2025 & 2035 (%)
TABLE 46: U.S. Joint Replacement Devices Market: Knee Replacement Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: U.S. Joint Replacement Devices Market: Hip Replacement Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: U.S. Joint Replacement Devices Market: Shoulder Replacement Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. Joint Replacement Devices Market: Ankle Replacement Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. Joint Replacement Devices Market: Elbow, Wrist and Other Joint Replacement Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. Joint Replacement Devices Market: Procedure Type Snapshot, 2025
TABLE 52: Segment Dashboard; Definition and Scope, by Procedure Type
TABLE 53: U.S. Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 54: U.S. Joint Replacement Devices Market: Segment Share Analysis, by Procedure Type, 2025 & 2035 (%)
TABLE 55: U.S. Joint Replacement Devices Market: Primary Total Joint Replacement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Joint Replacement Devices Market: Partial and Bone-Preserving Joint Replacement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. Joint Replacement Devices Market: Revision Joint Replacement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. Joint Replacement Devices Market: Resurfacing and Conversion Procedures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. Joint Replacement Devices Market: Complex and Oncologic Reconstruction Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: U.S. Joint Replacement Devices Market: End User Snapshot, 2025
TABLE 61: Segment Dashboard; Definition and Scope, by End User
TABLE 62: U.S. Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 63: U.S. Joint Replacement Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 64: U.S. Joint Replacement Devices Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. Joint Replacement Devices Market: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Joint Replacement Devices Market: Orthopedic Specialty Hospitals Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Joint Replacement Devices Market: Academic and Tertiary Referral Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. Joint Replacement Devices Market: Community Hospitals and Regional Orthopedic Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: U.S. Joint Replacement Devices Market: Technology Type Snapshot, 2025
TABLE 70: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 71: U.S. Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 72: U.S. Joint Replacement Devices Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 73: U.S. Joint Replacement Devices Market: Conventional Instrumented Joint Replacement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Joint Replacement Devices Market: Computer-Assisted Navigation Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Joint Replacement Devices Market: Robotic-Assisted Joint Replacement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Joint Replacement Devices Market: Patient-Specific and Three-Dimensional Planning Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. Joint Replacement Devices Market: Sensor-, Data- and AI-Enabled Arthroplasty Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: U.S. Joint Replacement Devices Market: Regional Snapshot, 2025
TABLE 79: Segment Dashboard; Definition and Scope, by Region
TABLE 80: U.S. Joint Replacement Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 81: U.S. Joint Replacement Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 82: West Region U.S. Joint Replacement Devices Market: Regional Overview and Trends
TABLE 83: West Region U.S. Joint Replacement Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 84: West Region U.S. Joint Replacement Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 85: West Region U.S. Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 86: West Region U.S. Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 87: West Region U.S. Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 88: West Region U.S. Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 89: West Region U.S. Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 90: California Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 91: California Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 92: California Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 93: California Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 94: California Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 95: Washington Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 96: Washington Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 97: Washington Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 98: Washington Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 99: Washington Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 100: Arizona Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 101: Arizona Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 102: Arizona Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 103: Arizona Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 104: Arizona Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 105: Colorado Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 106: Colorado Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 107: Colorado Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 108: Colorado Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 109: Colorado Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 110: Oregon Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 111: Oregon Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 112: Oregon Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 113: Oregon Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 114: Oregon Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 115: Utah Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 116: Utah Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 117: Utah Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 118: Utah Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 119: Utah Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 120: Nevada Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 121: Nevada Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 122: Nevada Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 123: Nevada Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 124: Nevada Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 125: New Mexico Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 126: New Mexico Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 127: New Mexico Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 128: New Mexico Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 129: New Mexico Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 130: Idaho Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 131: Idaho Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 132: Idaho Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 133: Idaho Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 134: Idaho Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 135: Montana Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 136: Montana Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 137: Montana Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 138: Montana Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 139: Montana Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 140: Wyoming Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 141: Wyoming Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 142: Wyoming Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 143: Wyoming Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 144: Wyoming Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 145: Alaska Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 146: Alaska Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 147: Alaska Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 148: Alaska Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 149: Alaska Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 150: Hawaii Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 151: Hawaii Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 152: Hawaii Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 153: Hawaii Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 154: Hawaii Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 155: Northeast Region U.S. Joint Replacement Devices Market: Regional Overview and Trends
TABLE 156: Northeast Region U.S. Joint Replacement Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 157: Northeast Region U.S. Joint Replacement Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 158: Northeast Region U.S. Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 159: Northeast Region U.S. Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 160: Northeast Region U.S. Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 161: Northeast Region U.S. Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 162: Northeast Region U.S. Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 163: New York Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 164: New York Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 165: New York Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 166: New York Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 167: New York Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 168: Massachusetts Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 169: Massachusetts Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 170: Massachusetts Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 171: Massachusetts Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 172: Massachusetts Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 173: New Jersey Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 174: New Jersey Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 175: New Jersey Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 176: New Jersey Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 177: New Jersey Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 178: Pennsylvania Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 179: Pennsylvania Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 180: Pennsylvania Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 181: Pennsylvania Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 182: Pennsylvania Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 183: Connecticut Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 184: Connecticut Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 185: Connecticut Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 186: Connecticut Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 187: Connecticut Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 188: Maine Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 189: Maine Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 190: Maine Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 191: Maine Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 192: Maine Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 193: Vermont Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 194: Vermont Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 195: Vermont Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 196: Vermont Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 197: Vermont Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 198: New Hampshire Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 199: New Hampshire Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 200: New Hampshire Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 201: New Hampshire Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 202: New Hampshire Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 203: Rhode Island Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 204: Rhode Island Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 205: Rhode Island Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 206: Rhode Island Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 207: Rhode Island Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 208: Delaware Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 209: Delaware Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 210: Delaware Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 211: Delaware Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 212: Delaware Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 213: South Region U.S. Joint Replacement Devices Market: Regional Overview and Trends
TABLE 214: South Region U.S. Joint Replacement Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 215: South Region U.S. Joint Replacement Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 216: South Region U.S. Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 217: South Region U.S. Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 218: South Region U.S. Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 219: South Region U.S. Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 220: South Region U.S. Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 221: Texas Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 222: Texas Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 223: Texas Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 224: Texas Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 225: Texas Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 226: Florida Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 227: Florida Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 228: Florida Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 229: Florida Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 230: Florida Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 231: Georgia Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 232: Georgia Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 233: Georgia Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 234: Georgia Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 235: Georgia Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 236: North Carolina Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 237: North Carolina Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 238: North Carolina Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 239: North Carolina Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 240: North Carolina Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 241: Tennessee Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 242: Tennessee Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 243: Tennessee Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 244: Tennessee Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 245: Tennessee Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 246: South Carolina Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 247: South Carolina Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 248: South Carolina Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 249: South Carolina Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 250: South Carolina Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 251: Alabama Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 252: Alabama Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 253: Alabama Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 254: Alabama Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 255: Alabama Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 256: Mississippi Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 257: Mississippi Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 258: Mississippi Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 259: Mississippi Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 260: Mississippi Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 261: Louisiana Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 262: Louisiana Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 263: Louisiana Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 264: Louisiana Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 265: Louisiana Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 266: Arkansas Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 267: Arkansas Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 268: Arkansas Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 269: Arkansas Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 270: Arkansas Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 271: Kentucky Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 272: Kentucky Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 273: Kentucky Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 274: Kentucky Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 275: Kentucky Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 276: Oklahoma Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 277: Oklahoma Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 278: Oklahoma Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 279: Oklahoma Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 280: Oklahoma Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 281: Virginia Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 282: Virginia Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 283: Virginia Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 284: Virginia Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 285: Virginia Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 286: Maryland Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 287: Maryland Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 288: Maryland Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 289: Maryland Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 290: Maryland Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 291: West Virginia Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 292: West Virginia Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 293: West Virginia Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 294: West Virginia Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 295: West Virginia Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 296: Midwest Region U.S. Joint Replacement Devices Market: Regional Overview and Trends
TABLE 297: Midwest Region U.S. Joint Replacement Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 298: Midwest Region U.S. Joint Replacement Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 299: Midwest Region U.S. Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 300: Midwest Region U.S. Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 301: Midwest Region U.S. Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 302: Midwest Region U.S. Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 303: Midwest Region U.S. Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 304: Illinois Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 305: Illinois Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 306: Illinois Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 307: Illinois Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 308: Illinois Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 309: Ohio Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 310: Ohio Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 311: Ohio Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 312: Ohio Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 313: Ohio Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 314: Michigan Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 315: Michigan Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 316: Michigan Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 317: Michigan Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 318: Michigan Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 319: Minnesota Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 320: Minnesota Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 321: Minnesota Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 322: Minnesota Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 323: Minnesota Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 324: Indiana Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 325: Indiana Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 326: Indiana Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 327: Indiana Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 328: Indiana Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 329: Wisconsin Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 330: Wisconsin Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 331: Wisconsin Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 332: Wisconsin Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 333: Wisconsin Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 334: Missouri Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 335: Missouri Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 336: Missouri Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 337: Missouri Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 338: Missouri Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 339: Iowa Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 340: Iowa Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 341: Iowa Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 342: Iowa Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 343: Iowa Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 344: Kansas Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 345: Kansas Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 346: Kansas Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 347: Kansas Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 348: Kansas Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 349: Nebraska Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 350: Nebraska Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 351: Nebraska Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 352: Nebraska Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 353: Nebraska Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 354: North Dakota Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 355: North Dakota Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 356: North Dakota Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 357: North Dakota Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 358: North Dakota Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 359: South Dakota Joint Replacement Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 360: South Dakota Joint Replacement Devices Market, by Joint Type, 2021–2035 (US$ Billion)
TABLE 361: South Dakota Joint Replacement Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 362: South Dakota Joint Replacement Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 363: South Dakota Joint Replacement Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 364: U.S. Joint Replacement Devices Market: Competitive Landscape Snapshot, 2025
TABLE 365: U.S. Joint Replacement Devices Market: Key Company Market Share Analysis, 2025
TABLE 366: U.S. Joint Replacement Devices Market: Company Positioning Matrix
TABLE 367: U.S. Joint Replacement Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 368: U.S. Joint Replacement Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 369: Stryker Corporation: Company Profile
TABLE 370: Zimmer Biomet Holdings, Inc.: Company Profile
TABLE 371: DePuy Synthes – Johnson & Johnson MedTech: Company Profile
TABLE 372: Smith+Nephew: Company Profile
TABLE 373: Enovis Corporation: Company Profile
TABLE 374: Exactech, Inc.: Company Profile
TABLE 375: MicroPort Orthopedics Inc.: Company Profile
TABLE 376: Corin Group: Company Profile
TABLE 377: Medacta International: Company Profile
TABLE 378: United Orthopedic Corporation: Company Profile
TABLE 379: Aesculap, Inc. – B. Braun: Company Profile
TABLE 380: restor3d, Inc.: Company Profile
TABLE 381: Conformis, Inc.: Company Profile
TABLE 382: THINK Surgical, Inc.: Company Profile
TABLE 383: OrthAlign, Inc.: Company Profile
TABLE 384: Monogram Technologies Inc.: Company Profile
TABLE 385: Maxx Orthopedics, Inc.: Company Profile
TABLE 386: Kinamed Incorporated: Company Profile
TABLE 387: Waldemar LINK GmbH & Co. KG: Company Profile
TABLE 388: Heraeus Medical: Company Profile
TABLE 389: SINTX Technologies, Inc.: Company Profile
TABLE 390: Onkos Surgical: Company Profile
TABLE 391: Catalyst Orthoscience Inc.: Company Profile
TABLE 392: Shoulder Innovations, Inc.: Company Profile
TABLE 393: Paragon 28 – Zimmer Biomet: Company Profile
TABLE 394: U.S. Joint Replacement Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 395: U.S. Joint Replacement Devices Market: Disruptive Technologies Impact Matrix
TABLE 396: U.S. Joint Replacement Devices Market: Emerging Business Trends
TABLE 397: U.S. Joint Replacement Devices Market: Business Opportunities for Startups and Existing Players
TABLE 398: U.S. Joint Replacement Devices Market: Investment Prioritization Matrix
TABLE 399: U.S. Joint Replacement Devices Market: Strategic Recommendations for Device Manufacturers
TABLE 400: U.S. Joint Replacement Devices Market: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 401: U.S. Joint Replacement Devices Market: Strategic Recommendations for Orthopedic ASCs and Specialty Hospitals
TABLE 402: U.S. Joint Replacement Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 403: U.S. Joint Replacement Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 404: U.S. Joint Replacement Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 405: U.S. Joint Replacement Devices Market: Go-to-Market Strategy and Portfolio Expansion Guidance
TABLE 406: U.S. Joint Replacement Devices Market: Scope Limitation
TABLE 407: U.S. Joint Replacement Devices Market: Data Use Limitation
TABLE 408: U.S. Joint Replacement Devices Market: Forecasting Limitation
TABLE 409: U.S. Joint Replacement Devices Market: Legal Disclaimer
TABLE 410: U.S. Joint Replacement Devices Market: Third-Party Data Disclaimer
TABLE 411: U.S. Joint Replacement Devices Market: Procedure-Volume Estimation Limitation
TABLE 412: U.S. Joint Replacement Devices Market: State-Level Market Allocation Limitation
TABLE 413: U.S. Joint Replacement Devices Market: Regulatory and Reimbursement Change Disclaimer

List of Figures

FIGURE 1: U.S. Joint Replacement Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: Supply Chain Analysis
FIGURE 5: PESTEL Analysis
FIGURE 6: Porter’s Five Forces Analysis
FIGURE 7: Market Attractiveness Analysis
FIGURE 8: Market Dynamics
FIGURE 9: Innovation & Patent Landscape, 2021–2025
FIGURE 10: Clinical Workflow Economics Framework
FIGURE 11: Hospital Capital Procurement Decision Framework
FIGURE 12: U.S. Joint Replacement Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 13: U.S. Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 14: U.S. Joint Replacement Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 15: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 16: Product Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 17: Joint Replacement Implants Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 18: Procedure-Specific Instruments Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 19: Fixation Materials and Surgical Accessories Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Robotic and Navigation Enabling Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Patient-Specific and Custom Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Joint Type Segment Market Share Analysis, 2025 & 2035
FIGURE 23: Joint Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Knee Replacement Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Hip Replacement Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Shoulder Replacement Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Ankle Replacement Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Elbow, Wrist and Other Joint Replacement Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Procedure Type Segment Market Share Analysis, 2025 & 2035
FIGURE 30: Procedure Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Primary Total Joint Replacement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Partial and Bone-Preserving Joint Replacement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Revision Joint Replacement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Resurfacing and Conversion Procedures Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Complex and Oncologic Reconstruction Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 37: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Ambulatory Surgery Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Orthopedic Specialty Hospitals Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Academic and Tertiary Referral Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Community Hospitals and Regional Orthopedic Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 44: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Conventional Instrumented Joint Replacement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Computer-Assisted Navigation Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Robotic-Assisted Joint Replacement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Patient-Specific and Three-Dimensional Planning Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Sensor-, Data- and AI-Enabled Arthroplasty Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 51: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: West Region U.S. Joint Replacement Devices Market Share and Leading Players, 2025
FIGURE 53: West Region Market Share Analysis by State, 2025
FIGURE 54: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: California Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Washington Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Arizona Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: Colorado Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: Oregon Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Utah Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Nevada Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: New Mexico Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Idaho Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Montana Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Wyoming Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Alaska Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Hawaii Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Northeast Region U.S. Joint Replacement Devices Market Share and Leading Players, 2025
FIGURE 69: Northeast Region Market Share Analysis by State, 2025
FIGURE 70: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: New York Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Massachusetts Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: New Jersey Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Pennsylvania Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Connecticut Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Maine Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Vermont Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: New Hampshire Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Rhode Island Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Delaware Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: South Region U.S. Joint Replacement Devices Market Share and Leading Players, 2025
FIGURE 82: South Region Market Share Analysis by State, 2025
FIGURE 83: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Texas Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Florida Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Georgia Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: North Carolina Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Tennessee Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: South Carolina Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Alabama Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Mississippi Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Louisiana Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Arkansas Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Kentucky Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Oklahoma Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Virginia Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Maryland Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: West Virginia Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Midwest Region U.S. Joint Replacement Devices Market Share and Leading Players, 2025
FIGURE 100: Midwest Region Market Share Analysis by State, 2025
FIGURE 101: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Illinois Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Ohio Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Michigan Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Minnesota Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Indiana Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Wisconsin Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Missouri Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Iowa Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Kansas Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Nebraska Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: North Dakota Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: South Dakota Joint Replacement Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 115: Company Positioning Matrix
FIGURE 116: Key Player Product Portfolio Benchmarking
FIGURE 117: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 118: Joint Replacement Device Innovation Roadmap
FIGURE 119: Robotic-Assisted Arthroplasty Adoption Roadmap
FIGURE 120: Patient-Specific and Three-Dimensional Printed Implant Opportunity Map
FIGURE 121: Outpatient Joint Replacement Growth Roadmap
FIGURE 122: Future Market Scenario Analysis, 2026–2035
FIGURE 123: Disruptive Technologies Impact Matrix
FIGURE 124: Emerging Business Trends Matrix
FIGURE 125: Investment Prioritization Matrix
FIGURE 126: Strategic Growth Roadmap for U.S. Joint Replacement Device Companies
FIGURE 127: Go-to-Market Strategy Framework
FIGURE 128: Product Positioning and Portfolio Expansion Framework
FIGURE 129: Report Scope and Disclaimer Framework